{"id":8248,"date":"2026-08-05T10:08:03","date_gmt":"2026-08-05T04:38:03","guid":{"rendered":"https:\/\/maxiomwealth.com\/blog\/?p=8248"},"modified":"2026-08-05T10:08:04","modified_gmt":"2026-08-05T04:38:04","slug":"should-you-apply-for-every-ipo-this-week","status":"publish","type":"post","link":"https:\/\/maxiomwealth.com\/blog\/should-you-apply-for-every-ipo-this-week\/","title":{"rendered":"Should You Apply For Every IPO This Week?"},"content":{"rendered":"

Two mainboard IPOs are live this week, and that timing puts a familiar question in front of retail investors. Manipal Health Enterprises lists on the NSE and BSE on August 5, 2026, at a price band of Rs 560-590 per share, while Dhoot Transmission opens for subscription from August 10 to August 12 at Rs 829-871 per share. When two large issues sit this close together, the instinct is to apply for both and let the grey market decide who wins. That instinct is a habit, not a strategy, and habits rarely allocate capital well.<\/p>\n\n

Should You Apply For Every IPO That Opens This Week?<\/h2>\n\n

No, applying for every mainboard IPO on offer spreads your capital thin without improving your odds of a meaningful allotment. Manipal Health Enterprises is raising a total of Rs 9,273.64 crore, split between a Rs 7,998.43 crore fresh issue and a Rs 1,275.22 crore offer for sale, and an issue this large typically pulls in heavy institutional and retail demand. Interestingly, ahead of listing, reported grey market activity showed the stock trading at a mild discount of Rs 5-6 against the Rs 590 upper band, a cautious signal rather than an obvious green light. Treating every issue open in a given week as equally worth your money ignores exactly this kind of difference.<\/p>\n\n

What Do This Week’s Two IPOs Actually Look Like On Paper?<\/h2>\n\n

Manipal Health Enterprises, headquartered in Bengaluru and incorporated in 2010, runs one of India’s largest private networks of multi-specialty hospitals, clinics and diagnostic centres. Dhoot Transmission is raising roughly Rs 3,066.89 crore at the upper band, combining a Rs 1,400 crore fresh issue with an offer for sale of about 1.9 crore shares that includes a stake sale by existing investor Bain Capital, with anchor bidding opening August 7. Laid side by side, the two issues differ in sector, size and the signal their early grey market activity is sending.<\/p>\n\n

<\/colgroup>
Detail<\/th>Manipal Health Enterprises<\/th>Dhoot Transmission<\/th><\/tr><\/thead>
Price band<\/td>Rs 560-590 per share<\/td>Rs 829-871 per share<\/td><\/tr>
Total issue size<\/td>Rs 9,273.64 crore<\/td>Approx Rs 3,066.89 crore (upper band)<\/td><\/tr>
Fresh issue<\/td>Rs 7,998.43 crore<\/td>Rs 1,400 crore<\/td><\/tr>
Offer for sale<\/td>Rs 1,275.22 crore<\/td>Approx 1.9 crore shares (incl. Bain Capital stake sale)<\/td><\/tr>
Key dates<\/td>Listing on NSE and BSE, August 5, 2026<\/td>Anchor bidding August 7; subscription August 10-12<\/td><\/tr>
Sector<\/td>Private healthcare, hospitals and diagnostics<\/td>Auto components and transmission systems<\/td><\/tr><\/tbody><\/table><\/figure>\n\n

Why Does Applying To Every IPO Hurt Your Returns Per Rupee?<\/h2>\n\n

Allocation in an oversubscribed mainboard IPO is prorated, so a large application does not guarantee a large allotment. In fact, most retail investors who apply for the maximum permissible lot in a heavily subscribed issue still end up with a single lot, or none at all, once the shares are divided across every applicant. Hence, when you split a fixed pool of investable money across two mainboard IPOs opening in the same week, you shrink the amount actually working toward the issue your research favours most. Suppose you have set aside Rs 2 lakh for IPO opportunities this month, dividing it evenly leaves Rs 1 lakh locked in each application for several days, while allotment probability works against you in both. Clearly, spreading thin across every listing does not raise your odds, it only adds paperwork.<\/p>\n\n

What Is The Opportunity Cost Of Money Locked In An IPO Application?<\/h2>\n\n

Funds blocked through the ASBA process stay locked from the day you apply until refund or allotment is credited, a wait that usually runs close to a week. That money earns nothing while blocked, so applying to both issues means running two bets that pay zero return during the waiting period. Indeed, that idle stretch matters more when the IPO is not a clear fit for your goals. Capital left invested through a diversified route instead can be compared using a lumpsum investment calculator<\/a>, which shows how steady compounding over a similar stretch often outweighs a week of uncertain IPO upside.<\/p>\n\n

How Should You Decide Which IPO Deserves Your Application?<\/h2>\n\n

A sound decision rests on three checks, not one grey market number. First, look at business quality: does the company operate in a sector you understand, with a revenue model that will still make sense five years out, hospitals and diagnostic chains carry different demand drivers than an auto component supplier tied to global capital expenditure cycles. Second, weigh whether the price band looks reasonable against comparable listed peers rather than pure subscription momentum. Third, check portfolio fit, an investor who already holds healthcare or auto-ancillary exposure through mutual funds gains little from adding a concentrated new position via an IPO. A monthly savings habit tracked through a SIP calculator<\/a> should stay the core plan, with an occasional IPO as a complement, not a competitor. Investors who would rather skip this stock-by-stock filtering altogether can route fresh equity money through a professionally managed equity portfolio<\/a>, which applies business quality and valuation checks across the market on an ongoing basis.<\/p>\n\n

Is Grey Market Premium A Reliable Signal Before You Apply?<\/h2>\n\n

Grey market premium is an unofficial, unregulated indicator, not a guarantee of listing gains. For large mainboard IPOs that draw strong institutional subscription, GMP has historically pointed in the correct direction around 60-70% of the time, a useful data point, not a promise. That leaves a real chance, one in three to two in five, of the signal pointing the wrong way. Ahead of listing, Manipal Health Enterprises showed a mild GMP discount rather than a premium, worth noting rather than dismissing. Use GMP as one input alongside business quality and price reasonableness, never as the sole reason to apply.<\/p>\n\n

Frequently Asked Questions<\/h2>\n\n

Can I apply for both Manipal Health Enterprises and Dhoot Transmission?<\/strong> Yes, there is no rule against applying to both, but doing so splits your available capital and locks two separate amounts through the ASBA process at the same time, so weigh whether both issues genuinely fit your portfolio before applying to each.<\/p>\n\n

Does a higher grey market premium mean I should apply?<\/strong> Not on its own, GMP has historically been directionally correct around 60-70% of the time for large, well-subscribed mainboard IPOs, which makes it one useful input, not a standalone reason to apply.<\/p>\n\n

What happens to my money if I do not get allotment?<\/strong> Under the ASBA process, funds are only blocked in your bank account, not debited, and the blocked amount is released automatically once allotment is finalised and you receive no shares.<\/p>\n\n

Should a small investor apply for large IPOs like Manipal Health Enterprises?<\/strong> A small investor can apply for a single retail lot within the price band, but should still check whether the issue fits their existing sector exposure rather than applying purely because the issue size is large.<\/p>\n\n

Is it better to apply for one IPO with conviction or several with small amounts?<\/strong> Concentrating your available IPO budget on the one issue that clears your business quality and pricing checks usually gives a cleaner outcome than splitting a small amount across several issues on GMP headlines alone.<\/p>\n\n

To sum up, two large IPOs opening in the same week is not a reason to apply for both, it is a reason to compare them properly. Manipal Health Enterprises and Dhoot Transmission differ in sector, issue size and the grey market signal ahead of listing, and a retail investor gains more from checking business quality, price band reasonableness and portfolio fit than from chasing every issue on offer. Apply where the fit is genuine, and let the rest of your investable money keep working through your existing plan.<\/p>","protected":false},"excerpt":{"rendered":"

Two mainboard IPOs are live this week, and that timing puts a familiar question in front of retail investors. Manipal Health Enterprises lists on the NSE and BSE on August 5, 2026, at a price band of Rs 560-590 per share, while Dhoot Transmission opens for subscription from August 10 to August 12 at Rs… Read More »Should You Apply For Every IPO This Week?<\/span><\/a><\/p>\n","protected":false},"author":3,"featured_media":8257,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[1282,1285,1284,1286],"class_list":["post-8248","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-financial-planning-money-matters-investment-advisor","tag-grey-market-premium","tag-ipo-allotment","tag-ipo-investing","tag-portfolio-planning"],"_links":{"self":[{"href":"https:\/\/maxiomwealth.com\/blog\/wp-json\/wp\/v2\/posts\/8248","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/maxiomwealth.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/maxiomwealth.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/maxiomwealth.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/maxiomwealth.com\/blog\/wp-json\/wp\/v2\/comments?post=8248"}],"version-history":[{"count":1,"href":"https:\/\/maxiomwealth.com\/blog\/wp-json\/wp\/v2\/posts\/8248\/revisions"}],"predecessor-version":[{"id":8256,"href":"https:\/\/maxiomwealth.com\/blog\/wp-json\/wp\/v2\/posts\/8248\/revisions\/8256"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/maxiomwealth.com\/blog\/wp-json\/wp\/v2\/media\/8257"}],"wp:attachment":[{"href":"https:\/\/maxiomwealth.com\/blog\/wp-json\/wp\/v2\/media?parent=8248"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/maxiomwealth.com\/blog\/wp-json\/wp\/v2\/categories?post=8248"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/maxiomwealth.com\/blog\/wp-json\/wp\/v2\/tags?post=8248"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}